Freeline Therapeutics Holdings PLC (FRLN) has fallen Thursday morning, with the stock decreasing -5.07% in pre-market trading to 3.56. FRLN's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, Freeline Therapeutics Holdings PLC ranks higher than 1% of stocks. Freeline Therapeutics Holdings PLC has risen 13.29% over the past month, closing at $3.29 on September 7. During this period of time, the stock fell as low as $3.20 and as high as $4.45. FRLN has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.
FRLN has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on FRLN!